A Cochrane Review that included 737 studies involving 103,237 participants concludes that most patients given a drug to prevent nausea or vomiting after surgery will not benefit from it. While 10% to 28% of people benefit, between 90% and 72% don’t.
But between 1% and 5% of experience side-effects that can include headache, sedation, or dry mouth.
“A clinician and patient together need to balance the benefits and risks before giving anti-emetics,” says lead Review Author Dr John Carlisle, who is a consultant anaesthetist and intensivist at Torbay Hospital, in Torquay, UK.
Of the 60 drugs considered, nine were most effective: droperidol, metoclopramide, ondansetron, tropisetron, dolasetron, dexamethasone, cyclizine, ramosetron and granisetron. There was no evidence of difference between these drugs.
Julia Lampam | Source: alphagalileo
Further information: www.wiley.co.uk
www.thecochranelibrary.com
More articles from
Health and Medicine:
Does hormone treatment predispose patients to breast cancer?
21.11.2008 | CNRS (Délégation Paris Michel-Ange)
Mechanisms of cardiovascular disease and cancer give clues to new therapies
21.11.2008 | European Science Foundation
Sustainable garden roofs developed as a new construction material
21.11.2008 | Studies and Analyses
Bees declared the winners in Earthwatch’s ‘irreplaceable species’ battle
21.11.2008 | Ecology, The Environment and Conservation
Hairspray is linked to common genital birth defect
21.11.2008 | Studies and Analyses
The Automobile – The Transition from Energy Guzzler to Power Supplier
20.11.2008 | Event News
Ministers meet to define the role of space in delivering global objectives
18.11.2008 | Event News
156th Annual Acoustical Society of America (ASA) Meeting in Miami
28.10.2008 | Event News